FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318486517> ?p ?o ?g. }

• W2318486517 endingPage "50" @default.
• W2318486517 startingPage "41" @default.
• W2318486517 abstract "Murine alpha/beta interferon (IFN) inhibited the growth of myeloma cells in vitro. Independently of the cell growth inhibition, IFN also reduced the number of antibody secreting myeloma cells as measured by haemolytic plaque assay. The sensitivity of both MOPC 315 plasmacytoma cells and 4F4 hybridoma cells varied, though not to the same extent, depending on the dose of IFN used and the duration of exposure. Inhibition of PFC activity was observed after one day of IFN treatment while inhibition of cell growth was not detected until Day 2 of incubation. A dose of 20 u/ml IFN had no effect on the growth rate of MOPC 315 cells but with 100 u/ml the inhibition of growth was virtually complete. In contrast, an inhibition of PFC activity was observed at all the concentrations tested. The cell growth and PFC activity of 4F4 hybridoma cells, on the other hand, were both inhibited by IFN when used at concentrations as low as 1.25 u/ml. Incubation with higher concentrations of IFN resulted in a progressive reduction in cell growth and PFC activity of 4F4 cells, however to a lesser degree of inhibition compared to that observed with MOPC 315 cells. For example, although virtually 70% of MOPC 315 PFC could be inhibited by culture for two days in the presence of 100 u/ml, it was necessary to use 1,250 u/ml IFN for 4 days incubation before the similar level of PFC inhibition was achieved with 4F4 cells. IFN treatment resulted in an increase in both cellular volume and protein content and this effect was prevented when IFN was previously neutralised by a specific antiserum. IFN-treated cells also showed an inhibition in the incorporation of 3[H]-thymidine but no alteration in the rate of utilization of 35[S]-methionine, when compared with an equal number of control cells." @default.
• W2318486517 created "2016-06-24" @default.
• W2318486517 creator A5016322160 @default.
• W2318486517 creator A5038126430 @default.
• W2318486517 date "1984-01-01" @default.
• W2318486517 modified "2023-09-26" @default.
• W2318486517 title "Inhibition of Cell Division and Antibody Secretion by Murine Alpha/Beta Interferon: Effects on Plasmacytoma and Hybridoma Lymphoid Cells" @default.
• W2318486517 cites W1539606439 @default.
• W2318486517 cites W1583545851 @default.
• W2318486517 cites W1589608483 @default.
• W2318486517 cites W1775749144 @default.
• W2318486517 cites W1824052842 @default.
• W2318486517 cites W1915463086 @default.
• W2318486517 cites W1966359087 @default.
• W2318486517 cites W1969549045 @default.
• W2318486517 cites W1979741842 @default.
• W2318486517 cites W1984847613 @default.
• W2318486517 cites W1993319836 @default.
• W2318486517 cites W2000715195 @default.
• W2318486517 cites W2007847579 @default.
• W2318486517 cites W2008440914 @default.
• W2318486517 cites W2022285897 @default.
• W2318486517 cites W2040408033 @default.
• W2318486517 cites W2045051161 @default.
• W2318486517 cites W2052036382 @default.
• W2318486517 cites W2060897674 @default.
• W2318486517 cites W2060926084 @default.
• W2318486517 cites W2087038087 @default.
• W2318486517 cites W2089276240 @default.
• W2318486517 cites W2094465569 @default.
• W2318486517 cites W2094925210 @default.
• W2318486517 cites W2099408094 @default.
• W2318486517 cites W2128056949 @default.
• W2318486517 cites W2154305957 @default.
• W2318486517 cites W2165839029 @default.
• W2318486517 cites W2319797826 @default.
• W2318486517 cites W2325413489 @default.
• W2318486517 doi "https://doi.org/10.1089/jir.1984.4.41" @default.
• W2318486517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6715913" @default.
• W2318486517 hasPublicationYear "1984" @default.
• W2318486517 type Work @default.
• W2318486517 sameAs 2318486517 @default.
• W2318486517 citedByCount "1" @default.
• W2318486517 crossrefType "journal-article" @default.
• W2318486517 hasAuthorship W2318486517A5016322160 @default.
• W2318486517 hasAuthorship W2318486517A5038126430 @default.
• W2318486517 hasConcept C126322002 @default.
• W2318486517 hasConcept C134018914 @default.
• W2318486517 hasConcept C153911025 @default.
• W2318486517 hasConcept C159654299 @default.
• W2318486517 hasConcept C202751555 @default.
• W2318486517 hasConcept C203014093 @default.
• W2318486517 hasConcept C25642318 @default.
• W2318486517 hasConcept C2776178377 @default.
• W2318486517 hasConcept C2776364478 @default.
• W2318486517 hasConcept C2778690821 @default.
• W2318486517 hasConcept C2778964538 @default.
• W2318486517 hasConcept C2779707156 @default.
• W2318486517 hasConcept C2909179924 @default.
• W2318486517 hasConcept C54355233 @default.
• W2318486517 hasConcept C55493867 @default.
• W2318486517 hasConcept C62112901 @default.
• W2318486517 hasConcept C71924100 @default.
• W2318486517 hasConcept C81885089 @default.
• W2318486517 hasConcept C86803240 @default.
• W2318486517 hasConceptScore W2318486517C126322002 @default.
• W2318486517 hasConceptScore W2318486517C134018914 @default.
• W2318486517 hasConceptScore W2318486517C153911025 @default.
• W2318486517 hasConceptScore W2318486517C159654299 @default.
• W2318486517 hasConceptScore W2318486517C202751555 @default.
• W2318486517 hasConceptScore W2318486517C203014093 @default.
• W2318486517 hasConceptScore W2318486517C25642318 @default.
• W2318486517 hasConceptScore W2318486517C2776178377 @default.
• W2318486517 hasConceptScore W2318486517C2776364478 @default.
• W2318486517 hasConceptScore W2318486517C2778690821 @default.
• W2318486517 hasConceptScore W2318486517C2778964538 @default.
• W2318486517 hasConceptScore W2318486517C2779707156 @default.
• W2318486517 hasConceptScore W2318486517C2909179924 @default.
• W2318486517 hasConceptScore W2318486517C54355233 @default.
• W2318486517 hasConceptScore W2318486517C55493867 @default.
• W2318486517 hasConceptScore W2318486517C62112901 @default.
• W2318486517 hasConceptScore W2318486517C71924100 @default.
• W2318486517 hasConceptScore W2318486517C81885089 @default.
• W2318486517 hasConceptScore W2318486517C86803240 @default.
• W2318486517 hasIssue "1" @default.
• W2318486517 hasLocation W23184865171 @default.
• W2318486517 hasLocation W23184865172 @default.
• W2318486517 hasOpenAccess W2318486517 @default.
• W2318486517 hasPrimaryLocation W23184865171 @default.
• W2318486517 hasRelatedWork W2018670987 @default.
• W2318486517 hasRelatedWork W2034985166 @default.
• W2318486517 hasRelatedWork W2099160624 @default.
• W2318486517 hasRelatedWork W2316138963 @default.
• W2318486517 hasRelatedWork W2318486517 @default.
• W2318486517 hasRelatedWork W2411051449 @default.
• W2318486517 hasRelatedWork W2412512692 @default.
• W2318486517 hasRelatedWork W2417053667 @default.
• W2318486517 hasRelatedWork W2474106843 @default.

• next